Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, today announced a major milestone in the development of its Emperor Total Artificial ...

First scientific presentation of the Emperor Drive System architecture to the biomedical engineering community-TUCSON, Ariz., July 27, 2026 ...

Rolls-Royce (RYCEF)(RYCEY) raised its full-year profit forecast well above Wall Street expectations after reporting a 46% jump in first-half operating profit, driven by strong performance across its ...

Rolls-Royce Holdings earnings 2026: first-half underlying profit jumped 46% to £2.53 billion, beating analyst forecasts by ...

Editor’s Note: To watch John’s video presentation of this article, click here. The image of the lone fighter ace dominating ...

CareDx, Inc. ( CDNA) Q2 2026 Earnings Call July 30, 2026 4:30 PM EDT Hello, everyone. Thank you for joining us and welcome to the CareDx Q2 2026 Earnings Call. [Operator Instructions] I will now hand ...

Ralliant Corporation (“Ralliant” or the “Company”) (NYSE: RAL) today announced financial results for the second quarter of 2026. For the second quarter, revenue of $568 million was up 13% ...

Hello, everyone, and welcome to the IMI plc Interim Results 2026. My name is Nadia, and I'll be coordinating the call today. [Operator Instructions] I will now hand over to your host, Roy Twite, CEO, ...

(NASDAQ:OMCL) (“Omnicell,” “we,” “our,” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today reported financial results for the ...

Universal Display Corporation (OLED-2.89%) reported $152 million, compared to $172 million in the second quarter of 2025, ...

Xcel Energy Inc. (NASDAQ: XEL) today reported 2026 second quarter GAAP earnings of $586 million, or $0.93 per share, compared with $444 million, or $0.75 per share in the same period in 2025 and ...

Researchers developed a modified DNA platform designed to reduce innate immune activation while maintaining gene expression. The approach could provide durable, redosable genetic therapies without the ...